Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)
Clinical trial NCT01914367 · COMPLETED
Trial details
- NCT number
- NCT01914367
- Sponsor
- University Hospital, Ghent
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-25
- Primary completion
- 2015-09-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.